Showing results (811-820 of 1,595) with videos related to

Sort By:
Pageof 160
Archivos De La Sociedad Espanola De Oftalmologia|May 14, 2003
[Frequency doubling perimetry in terminal visual field defects]F J Muñoz-Negrete, G Rebolleda, J González Martín-Moro, et al.
European Journal of Neurology|November 29, 2013
The HhaI polymorphism in the CYP2D6 gene is not associated with Parkinson's disease in a Caucasian populationD J Nicholl, P Bennett, D B Ramsden, et al.
BMC Public Health|February 11, 2012
Drug education in Victorian schools (DEVS): the study protocol for a harm reduction focused school drug education trialRichard Midford, Helen Cahill, David Foxcroft, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|September 1, 1996
Reversible impairment in monocyte major histocompatibility complex class II expression in malnourished surgical patientsF K Welsh, S M Farmery, C Ramsden, et al.
European Journal of Pharmacology|April 4, 1997
Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with sigma receptorsS L Chan, A L Pallett, J Clews, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|April 1, 1989
A review of medical education and medical informaticsR B Haynes, M Ramsden, K A McKibbon, et al.
Sexually Transmitted Infections|May 18, 2022
Environmental contamination by Chlamydia trachomatis and Neisseria gonorrhoeae: is it time to change our infection control practices? Results of a regional studySophie Ramsden, Katie Ovens, James Griffiths, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2012
Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory diseaseMihiro Sunose, Kathryn Bell, Katie Ellard, et al.
International Journal of Circumpolar Health|August 4, 2021
Community led: celebrating wellness with a smileMarcella Ogenchuk, Robert St Pierre, Gerry Uswak, et al.
Lung|November 27, 2025
Synergistic Interactions Between the Quinolone-Derived Compound HT61 and Tobramycin Against a Range of Clinical Isolates of Pseudomonas aeruginosa In VitroB Ramsden, A V Kelis, M-E Faure, et al.
Pageof 160